Filter your search
PharmaceuticalsX
Kalorama Information is a dependable resource for information on opportunity in the pharmaceutical market. The pharma industry has seen important developments in the last few years, bringing both challenges and new opportunities. The industry outlook for many manufacturers has changed due to outsourcing in drug discovery, growing generic competition and greater interest in biotechnology, among other developments. Our reports provide the sales data, revenue forecasts, and competitive analysis that one needs to understand the market.
Vaccines
Drug Delivery
Over-the-Counter
Drug Discovery
Cancer Treatment
Manufacturing & Packaging
Prescription Drugs
- $5,600.00 – $8,000.00The Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030) report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in […]April 11, 2025$7,000.00 – $10,000.00The CGT market is evolving rapidly, with billions in investments and thousands of strategic deals shaping its trajectory. Companies that understand the landscape and anticipate future deal trends will have the competitive edge needed to thrive. Whether you are a biotech executive, investor, R&D leader, or regulatory strategist, this report provides data-driven insights to inform […]February 13, 2025$6,300.00 – $12,600.00Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other […]June 3, 2024$5,000.00 – $10,500.00Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in new therapies […]April 30, 2024$5,000.00 – $10,500.00Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. […]February 22, 2024$5,000.00 – $10,000.00While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years. Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area. There are now many approved […]December 8, 2023$5,000.00 – $10,000.00This report, Kalorama’s Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity in cell and gene therapy. The report includes specific details of 1000+ deals from 2022-2023. A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama’s CGT deals amounted to a […]May 22, 2023$5,000.00 – $10,000.00Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the […]October 25, 2022$5,000.00 – $10,000.00V A C C I N E M A R K E T E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion. That’s up from $34.1 billion in 2017, and just $25 billion in 2010. Infectious […]September 23, 2022$6,000.00 – $12,000.00This report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensive coverage of the biotechnology segment of the global BCMO industry. Sales estimates are provided by segment and region, expressed in current dollars. Estimates are provided for […]August 2, 2022